Federal Court of Appeal affirms prohibition order against Apotex regarding abiraterone

Published date06 April 2021
Subject MatterAppeals,Obviousness,Patent-Eligible Subject Matter,Patent Litigation,Pharmaceutical Patents,Canada,Patent Infringement,Apotex,Janssen Pharmaceuticals,Patent Invalidity,Patented Medicines,PMNOC Regulations
AuthorKatie Lee
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT